Cardinal Health (United States)
In research, Cardinal Health (United States) stands highest in Medicine (#9,928 of 10,443 worldwide) and Health Sciences (#11,579 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #24,943 of 28,054 · #30,653 all time
- Rank in United States
- #3,755 of 4,192
- Research works
- 446 ▲ 163% vs 2013–17
- Citations
- 4.3k 9.7 per fractional work
- Top-10% rate
- 6.6% record average 16.5%
- Open access
- 30% world 28%
What is Cardinal Health (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,928 of 10,443 | 4.3% | 63 | #15039 | |
| Health SciencesDomain | #11,579 of 11,982 | 4.3% | 67 | #16833 |
Each strip is that field’s whole ranked pool, with the notch where Cardinal Health (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 4.3×. Every wedge is a field page.
- Economics, Econometrics and Finance 4.3×
- Medicine 3.0×
- Immunology and Microbiology 3.0×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Health Professions 1.3×
- Mathematics 1.2×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Business, Management and Accounting 0.7×
- Earth and Planetary Sciences 0.6×
- Decision Sciences 0.6×
- Computer Science 0.5×
- Physics and Astronomy 0.3×
- Chemistry 0.2×
- Engineering 0.2×
- Neuroscience 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Chemical Engineering 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
- Materials Science 0.0×
Who are the top researchers at Cardinal Health (United States)?
Ranked on the composite score, Katherine M. Shea, Jonathan Kish and Ajeet Gajra lead among researchers whose main affiliation is Cardinal Health (United States).
- 1 Katherine M. Shea United States · #713,125 worldwide 47 citations · 16 works
- 2 Jonathan Kish United States · #806,314 worldwide 26 citations · 17 works
- 3 Ajeet Gajra United States · #988,732 worldwide 33 citations · 36 works
- 4 Andrew J. Klink United States · #1,098,609 worldwide 22 citations · 24 works
- 5 Patricia C. Kienle United States · #1,196,069 worldwide 4 citations · 28 works
- 6 Bruce A. Feinberg United States · #1,243,880 worldwide 24 citations · 68 works
- 7 Kristin M. Zimmerman Savill United States · #1,249,948 worldwide 14 citations · 17 works
- 8 Yolaine Jeune‐Smith United States · #1,542,430 worldwide 1 citations · 19 works
- 9 Janna Radtchenko United States · #1,560,605 worldwide 7 citations · 17 works
Which keywords describe research at Cardinal Health (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Clinical Trials, Prognostic Factors, Lymphoma, Targeted Therapy, Chemotherapy, Quality of Life and Cancer Immunotherapy.
- Molecular Profiling
- PET Imaging
- Breast Cancer
- BCR-ABL
- International Myeloma Working Group
- Diagnosis Criteria
- Staging System
- Mutation
- Classification
- Rituximab
- Radiotherapy
- Health Utility Measures
- Minimal Residual Disease
- Cost of Care
- CAR T Cells
- Cancer Immunotherapy
- Chemotherapy
- Epidemiology
- Lymphoma
- Clinical Trials
- Immunotherapy
- Prognostic Factors
- Quality of Life
- Targeted Therapy
- Public Health
- Leukemia
- Chimeric Antigen Receptor
- Financial Toxicity
- Cost-effectiveness Analysis
- Precision Medicine
- Genomic Profiling
- Treatment Guidelines
- Clinical Practice Guidelines
- Proteasome Inhibitors
- ALK Inhibitors
- EGFR Mutations
- Neoadjuvant Therapy
- Imatinib
- Metastatic Breast Cancer
- Gene Expression Profiling
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy9▲ 11×9 topics
- Clinical Trials8▲ 11×7 topics
- Prognostic Factors7▲ 16×7 topics
- Lymphoma7▲ 40×3 topics
- Quality of Life7▲ 4.5×6 topics
- Epidemiology7▲ 1.60×24 topics
- Targeted Therapy7▲ 27×4 topics
- Chemotherapy6▲ 7.4×14 topics
- Public Health6▲ 3.5×13 topics
- Cancer Immunotherapy5▲ 30×2 topics
- Leukemia5▲ 56×2 topics
- CAR T Cells5▲ 61×1 topic
- Chimeric Antigen Receptor5▲ 61×1 topic
- Cost of Care5▲ 141×1 topic
- Financial Toxicity5▲ 141×1 topic
- Minimal Residual Disease4▲ 57×2 topics
- Cost-effectiveness Analysis4▲ 46×1 topic
- Health Utility Measures4▲ 46×1 topic
- Precision Medicine4▲ 7.4×6 topics
- Radiotherapy4▲ 9.1×6 topics
- Genomic Profiling4▲ 32×2 topics
- Rituximab3▲ 20×2 topics
- Treatment Guidelines3▲ 14×2 topics
- Classification3▲ 6.2×4 topics
- Clinical Practice Guidelines3▲ 5.3×5 topics
- Mutation3▲ 15×2 topics
- Proteasome Inhibitors3▲ 40×2 topics
- Staging System3▲ 46×2 topics
- ALK Inhibitors3▲ 44×1 topic
- Diagnosis Criteria3▲ 79×1 topic
- EGFR Mutations3▲ 44×1 topic
- International Myeloma Working Group3▲ 79×1 topic
- Neoadjuvant Therapy3▲ 11×3 topics
- BCR-ABL3▲ 94×1 topic
- Imatinib3▲ 94×1 topic
- Breast Cancer3▲ 10×3 topics
- Metastatic Breast Cancer2▲ 41×2 topics
- PET Imaging2▲ 14×3 topics
- Gene Expression Profiling2▲ 27×2 topics
- Molecular Profiling2▲ 22×2 topics
Which research topics does Cardinal Health (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Multiple Myeloma Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 5 works
- 2 Economic and Financial Impacts of Cancer Economics and Econometrics 5 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 4 Multiple Myeloma Research and Treatments Hematology 3 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 6 Chronic Myeloid Leukemia Treatments Hematology 3 works
- 7 Cancer Genomics and Diagnostics Cancer Research 2 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 10 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cardinal Health (United States)'s research output changed?
Output in 2018–2022 was 163% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dublin
- Center for Reliable Energy Systems
- Guild Associates (United States)
- Navidea Biopharmaceuticals (United States)
- LSP Technologies (United States)
- Ohio Sinus Institute
- Ohio Pain Initiative
- Samraksh (United States)
- Columbus Ophthalmology Associates
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.